Stocks
Neurocrine Biosciences (NBIX) FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | 137.3 | 217.6 | 233.1 | 322.9 | 361.6 | 440.1 | ||
| Changes by years, y/y, % | +79% | +58% | +7% | +39% | +12% | +36.4% | |||
Neurocrine Biosciences. FCF, bln rub
Neurocrine Biosciences. FCF, changes, %
Neurocrine Biosciences. FCF, sum by quarters, bln rub
Neurocrine Biosciences (NBIX) FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| FCF, bln rub | ? | 204.4 | 118.1 | 119.1 | 53.0 | 149.9 | 440.1 | |
| Changes by years, y/y, % | +103% | -16% | -189% | -69% | -27% | |||
| Changes by quarters, q/q, % | +18% | -42% | +1% | -55% | +183% | |||
